Complex networks approach for analyzing the correlation of traditional chinese medicine syndrome evolvement and cardiovascular events in patients with stable coronary heart disease.

PubWeight™: 0.79‹?›

🔗 View Article (PMC 4363617)

Published in Evid Based Complement Alternat Med on March 03, 2015

Authors

Zhuye Gao1, Siwei Li2, Qinghua Shang1, Yang Jiao2, Xuezhong Zhou3, Changgeng Fu1, Hao Xu4, Dazhuo Shi1, Keji Chen1

Author Affiliations

1: China Heart Institute of Chinese Medicine, China Academy of Chinese Medical Sciences, Beijing 100091, China.
2: Beijing University of Chinese Medicine, Beijing 100029, China.
3: School of Computer and Information Technology and Beijing Key Lab of Traffic Data Analysis and Mining, Beijing Jiaotong University, Beijing 100044, China.
4: Department of Cardiology, Xiyuan Hospital, China Academy of Chinese Medical Sciences, Beijing 100091, China.

Articles cited by this

Heart disease and stroke statistics--2014 update: a report from the American Heart Association. Circulation (2013) 28.02

Network medicine: a network-based approach to human disease. Nat Rev Genet (2011) 14.07

2013 ESC guidelines on the management of stable coronary artery disease: the Task Force on the management of stable coronary artery disease of the European Society of Cardiology. Eur Heart J (2013) 9.54

Controllability of complex networks. Nature (2011) 9.09

Mapping complex disease traits with global gene expression. Nat Rev Genet (2009) 7.44

Conserved pathways within bacteria and yeast as revealed by global protein network alignment. Proc Natl Acad Sci U S A (2003) 4.68

Blood stasis syndrome and its treatment with activating blood circulation to remove blood stasis therapy. Chin J Integr Med (2012) 1.17

Management of stable coronary artery disease. Lancet (2010) 1.00

[Analysis of relationships among syndrome, therapeutic treatment, and Chinese herbal medicine in patients with coronary artery disease based on complex networks]. Zhong Xi Yi Jie He Xue Bao (2010) 0.97

Syndrome classification based on manifold ranking for viral hepatitis. Chin J Integr Med (2013) 0.93

Health status and quality of life in patients with stable coronary artery disease and chronic kidney disease treated with optimal medical therapy or percutaneous coronary intervention (post hoc findings from the COURAGE trial). Am J Cardiol (2013) 0.92

Selecting an appropriate interestingness measure to evaluate the correlation between Chinese medicine syndrome elements and symptoms. Chin J Integr Med (2011) 0.88

Biomedical mechanisms of blood stasis syndrome of coronary heart disease by systems biology approaches. Chin J Integr Med (2013) 0.88

[The criterion of syndrome differentiation and quantification for stable coronary heart disease caused by etiological toxin of Chinese medicine]. Zhongguo Zhong Xi Yi Jie He Za Zhi (2011) 0.83

[Blood-stasis and toxin causing catastrophe hypothesis and acute cardiovascular events: proposal of the hypothesis and its clinical significance]. Zhongguo Zhong Xi Yi Jie He Za Zhi (2008) 0.82

Therapeutic evaluation on complex interventions of integrative medicine and the potential role of data mining. Chin J Integr Med (2010) 0.80

Network based integrated analysis of phenotype-genotype data for prioritization of candidate symptom genes. Biomed Res Int (2014) 0.79

Use of evidence-based pharmacotherapy for secondary prevention of coronary heart disease: a Chinese medicine hospital versus a general hospital. Chin J Integr Med (2014) 0.78

Multifactor dimensionality reduction analysis of the correlation of Chinese medicine syndrome evolvement and cardiovascular events in patients with stable coronary heart disease. Chin J Integr Med (2014) 0.78